Retraction Notice: The Role of CD276 in Promoting Sunitinib Resistance in Clear Cell Renal Cell Carcinoma Through DNA Damage Repair and FAK-MAPK Pathway Activation - Summary - MDSpire
Advertisement
Retraction Notice: The Role of CD276 in Promoting Sunitinib Resistance in Clear Cell Renal Cell Carcinoma Through DNA Damage Repair and FAK-MAPK Pathway Activation
To investigate the specific role of CD276 in promoting sunitinib resistance in clear cell renal cell carcinoma.
Key Findings:
The article was retracted due to issues with data integrity, including a request for correction regarding a duplicated image in Fig. 3c.
Discrepancies were found in the western blot scans and expected molecular weights.
The authors could not provide adequate explanations or original raw data.
Interpretation:
The retraction indicates a significant lack of confidence in the validity of the research findings, raising concerns about data integrity in the field.
Limitations:
Inability to verify the original data, which undermines the study's conclusions.
Concerns over image duplication in published figures, affecting the credibility of the results.
Conclusion:
The article has been retracted by the editors, and all authors have agreed to this decision, reflecting a consensus on the issues identified.
